cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA077957 | .e | 1 to 248 | 248 to 1 | tiling clone, | 248/248 (100 %) | 1 diff (99.6 %id) | |||
AA078310 | placenta | .b | 1740 to 1892 | 1 to 153 | 153/294 (52 %) | 1 diff (99.7 %id) | |||
AA247142 | .k | 1876 to 2047 | 1 to 169 | 169/178 (94 %) | 9 diff (95.0 %id) | ||||
AA314486 | colon | .a | 1335 to 1818 | 1 to 484 | 484/484 (100 %) | 1 diff (99.8 %id) | |||
AA328724 | .g | 3399 to 3645 | 1 to 248 | 248/248 (100 %) | 1 diff (99.6 %id) | ||||
DC298834 | adrenal gland | .a | 110 to 663 | 1 to 554 | 554/554 (100 %) | 1 diff (99.9 %id) | |||
AI133662 | Liver | .a | 2815 to 3466 | 652 to 1 | 652/652 (100 %) | 1 diff (99.9 %id) | |||
AK093584 | thymus | .a | 1419 to 3823 | 1 to 2404 | tiling clone, available from FLJ, | 2404/2404 (100 %) | 1 diff (100.0 %id) | ||
AK123044 | Prostate | .f | 1 to 2476 | 2 to 2477 | exact | tiling clone, available from FLJ, | 2477/2477 (100 %) | 3 diff (99.9 %id) | |
AK123600 | tongue, tumor tissue | .c | 28 to 3877 | 1 to 3850 | exact | tiling clone, available from FLJ, | 3850/3850 (100 %) | 0 diff (100 %id) | |
AK126674 | cerebellum | .g | 1 to 3791 | 2 to 3792 | exact | tiling clone, available from FLJ, | 3792/3792 (100 %) | 5 diff (99.9 %id) | |
AK293744 | cerebellum | .d | 1 to 3424 | 1 to 3424 | H667R M971V | tiling clone, | 3424/3424 (100 %) | 4 diff (99.9 %id) | |
AK307417 | adrenal gland | .a | 110 to 2197 | 1 to 2085 | 2085/2085 (100 %) | 6 diff (99.8 %id) | |||
AW390263 | stomach | .a | 2719 to 2995 | 18 to 296 | 279/296 (94 %) | 8 diff (97.3 %id) | |||
AW390801 | stomach | .a | 2628 to 3119 | 24 to 515 | 496/516 (96 %) | 13 diff (97.5 %id) | |||
AW391573 | stomach | .a | 2481 to 2702 | 17 to 236 | 220/247 (89 %) | 9 diff (96.4 %id) | |||
AW857615 | colon | .b | 848 to 1376 | 1 to 530 | 530/530 (100 %) | 11 diff (98.0 %id) | |||
AW857617 | colon | .b | 823 to 1376 | 19 to 573 | 555/573 (96 %) | 6 diff (99.0 %id) | |||
AW865627 | stomach_normal | .a | 593 to 963 | 11 to 381 | 371/381 (97 %) | 6 diff (98.5 %id) | |||
AW865640 | stomach_normal | .a | 757 to 890 | 142 to 10 | 133/142 (93 %) | 0 diff (100 %id) | |||
AW865647 | stomach_normal | .a | 776 to 1045 | 14 to 283 | 270/286 (94 %) | 5 diff (98.3 %id) | |||
AW865802 | stomach_normal | .a | 593 to 927 | 332 to 2 | 331/347 (95 %) | 0 diff (100 %id) | |||
AW865833 | stomach_normal | .a | 636 to 1020 | 391 to 10 | 382/391 (97 %) | 0 diff (100 %id) | |||
AW867972 | stomach_normal | .a | 1080 to 1606 | 20 to 547 | 528/547 (96 %) | 9 diff (98.4 %id) | |||
AW937777 | denis_drash | .a | 2326 to 2848 | 535 to 13 | Submitted on the opposite strand | 523/535 (97 %) | 1 diff (99.9 %id) | ||
AW958088 | .g | 3400 to 3789 | 1 to 390 | AAA | 390/390 (100 %) | 0 diff (100 %id) | |||
AW961409 | .g | 3400 to 3789 | 1 to 390 | AAA | 390/390 (100 %) | 0 diff (100 %id) | |||
AX748215 | .a | 1419 to 3823 | 1 to 2404 | 2404/2404 (100 %) | 1 diff (100.0 %id) | ||||
BC033781 | Testis, embryonal carcinoma | .a | 883 to 3823 | 12 to 2952 | tiling clone, available from MGC, AAA | 2941/2941 (100 %) | 1 diff (100.0 %id) | ||
BE762593 | nervous_tumor | .a | 1147 to 1513 | 17 to 384 | 368/385 (95 %) | 8 diff (98.0 %id) | |||
BE837363 | prostate_normal | .o-u | -9 to 435 | 1 to 445 | I2L N15H | tiling clone, | 445/451 (98 %) | 9 diff (98.1 %id) | |
BF746791 | breast | .a | 2394 to 2596 | 266 to 63 | Submitted on the opposite strand | 204/268 (76 %) | 0 diff (100 %id) | ||
BF815727 | colon_ins | .a | 2982 to 3340 | 17 to 375 | 359/375 (95 %) | 8 diff (97.9 %id) | |||
BF872822 | lung_tumor | .a | 1004 to 1207 | 1 to 204 | 204/204 (100 %) | 8 diff (96.1 %id) | |||
BF876036 | lung_tumor | .a | 967 to 1470 | 1 to 504 | 504/504 (100 %) | 2 diff (99.7 %id) | |||
BF907617 | uterus_tumor | .a | 2725 to 3152 | 25 to 449 | 425/449 (94 %) | 7 diff (98.5 %id) | |||
BF916607 | uterus_tumor | .a | 1809 to 2341 | 533 to 1 | Submitted on the opposite strand | 533/540 (98 %) | 4 diff (99.3 %id) | ||
BF916656 | uterus_tumor | .a | 1718 to 2201 | 1 to 484 | 484/484 (100 %) | 1 diff (99.8 %id) | |||
BG012561 | placenta_normal | .a | 392 to 736 | 440 to 95 | 346/441 (78 %) | 4 diff (99.1 %id) | |||
BG900296 | cartilage | .a | 888 to 1471 | 86 to 669 | 584/601 (97 %) | 6 diff (99.1 %id) | |||
DA044136 | bladder | .a | 1750 to 2324 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
BQ331032 | lung_tumor | .a | 1932 to 2404 | 499 to 24 | 476/506 (94 %) | 8 diff (98.5 %id) | |||
DC306614 | cerebellum | .d | 1 to 522 | 1 to 522 | 522/522 (100 %) | 1 diff (99.9 %id) | |||
DA096661 | cerebellum | .i | 1 to 568 | 2 to 570 | exact | tiling clone, capped | 569/569 (100 %) | 1 diff (99.9 %id) | |
DA099037 | cerebellum | .h | 8 to 559 | 2 to 553 | exact | tiling clone, capped | 552/552 (100 %) | 0 diff (100 %id) | |
DA103535 | cerebellum | .n | 1 to 545 | 2 to 547 | tiling clone, capped | 546/546 (100 %) | 1 diff (99.9 %id) | ||
DA107525 | cerebellum | .g | 1 to 545 | 2 to 547 | capped | 546/546 (100 %) | 2 diff (99.7 %id) | ||
DB299599 | cerebellum | .g | 3203 to 3791 | 588 to 1 | 588/588 (100 %) | 9 diff (98.5 %id) | |||
DA113464 | cerebellum | .h | 1 to 550 | 2 to 551 | tiling clone, capped | 550/550 (100 %) | 2 diff (99.7 %id) | ||
DA118721 | cerebellum | .a | 401 to 933 | 2 to 535 | capped | 534/534 (100 %) | 1 diff (99.9 %id) | ||
DA165237 | amygdala | .a | 1628 to 2080 | 2 to 454 | capped | 453/453 (100 %) | 5 diff (98.9 %id) | ||
DA215760 | brain | .a | 479 to 1019 | 2 to 542 | capped | 541/541 (100 %) | 0 diff (100 %id) | ||
DA327424 | hippocampus | .a | 235 to 575 | 224 to 564 | capped | 343/563 (60 %) | 6 diff (99.0 %id) | ||
BX096327 | melanocyte | .a | 890 to 1376 | 1 to 487 | 487/487 (100 %) | 2 diff (99.6 %id) | |||
BX116087 | liver and spleen | .k | 300 to 1032 | 1 to 741 | 741/748 (99 %) | 8 diff (99.0 %id) | |||
BX538201 | human rectum tumor | .a | 1337 to 3823 | 1 to 2487 | available from DKFZ, AAA | 2487/2487 (100 %) | 3 diff (99.9 %id) | ||
BX640616 | uterus | .b | 106 to 5616 | 1 to 5512 | K12E K143R Q249H | tiling clone, available from DKFZ, AAA | 5512/5512 (100 %) | 9 diff (99.9 %id) | |
CN314088 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1203 to 1363 | 1 to 161 | 161/161 (100 %) | 0 diff (100 %id) | |||
CN314089 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 124 to 827 | 1 to 703 | tiling clone, | 703/703 (100 %) | 3 diff (99.6 %id) | ||
CN314090 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 2810 to 3570 | 6 to 766 | 761/766 (99 %) | 7 diff (99.1 %id) | |||
CN314091 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 777 to 1389 | 1 to 612 | 612/612 (100 %) | 1 diff (99.9 %id) | |||
CN314092 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 215 to 665 | 1 to 451 | 451/451 (100 %) | 2 diff (99.6 %id) | |||
CR620095 | Placenta Cot 25-normalized | .k | 1 to 2770 | 1 to 2770 | exact | tiling clone, | 2770/2770 (100 %) | 0 diff (100 %id) | |
BX339052 | Placenta Cot 25-normalized | .k | 1681 to 2770 | 1084 to 1 | 1084/1084 (100 %) | 25 diff (97.7 %id) | |||
BX339053 | Placenta Cot 25-normalized | .k | 1 to 1005 | 1 to 1011 | exact | 1011/1016 (99 %) | 7 diff (99.4 %id) | ||
BX348972 | Placenta Cot 25-normalized | .k | 822 to 1810 | 1 to 972 | 972/975 (99 %) | 9 diff (99.1 %id) | |||
BX371855 | Placenta Cot 25-normalized | .k | 1089 to 1934 | 838 to 1 | 838/961 (87 %) | 65 diff (93.3 %id) | |||
DA456106 | tongue, tumor tissue | .c | 29 to 589 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DB314368 | tongue, tumor tissue | .c | 3358 to 3877 | 520 to 1 | 520/520 (100 %) | 0 diff (100 %id) | |||
CV030593 | mixed | .a | 1092 to 1789 | 1 to 698 | 698/698 (100 %) | 7 diff (99.0 %id) | |||
CV403595 | colon | .b | 810 to 1382 | 1 to 572 | 572/572 (100 %) | 17 diff (97.1 %id) | |||
D30968 | .a | 2459 to 2704 | 1 to 247 | 247/251 (98 %) | 2 diff (99.3 %id) | ||||
D31333 | .a | 2459 to 2806 | 1 to 348 | 348/360 (96 %) | 2 diff (99.5 %id) | ||||
DA473383 | .a | 619 to 1186 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
DA479436 | .a | 1481 to 2044 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | |||
AL596876 | .b | 652 to 1034 | 93 to 474 | 382/474 (80 %) | 6 diff (98.8 %id) | ||||
AL042281 | testis | .a | 2459 to 2914 | 1 to 457 | 457/457 (100 %) | 3 diff (99.4 %id) | |||
AL705548 | human skeletal muscle | .a | 665 to 1142 | 1 to 478 | 478/478 (100 %) | 0 diff (100 %id) | |||
AL706240 | human skeletal muscle | .l-u | 1 to 671 | 2 to 672 | A5X | tiling clone, | 672/672 (100 %) | 9 diff (98.7 %id) | |
AL135690 | melanoma (MeWo cell line) | .a | 3121 to 3646 | 1 to 527 | 527/531 (99 %) | 7 diff (98.7 %id) | |||
DW437413 | Liver | .b | 1 to 233 | 17 to 249 | tiling clone, | 233/249 (93 %) | 6 diff (97.6 %id) | ||
DA501979 | brain | .a | 1302 to 1853 | 2 to 553 | capped | 552/552 (100 %) | 1 diff (99.9 %id) | ||
CD671357 | eye, Iris | .a | 2601 to 3215 | 1 to 615 | 615/615 (100 %) | 3 diff (99.6 %id) | |||
FN163117 | breast carcinoma | .g | 3310 to 3378 | 1 to 67 | 67/67 (100 %) | 6 diff (91.1 %id) | |||
AV687268 | hepatocellular carcinoma | .g | 3517 to 3789 | 19 to 291 | AAA | 273/291 (93 %) | 6 diff (98.0 %id) | ||
AV690580 | hepatocellular carcinoma | .g | 3440 to 3789 | 8 to 351 | AAA | 344/351 (98 %) | 6 diff (98.3 %id) | ||
BP420571 | small intestine | .a | 3122 to 3629 | 1 to 508 | Submitted on the opposite strand | 508/508 (100 %) | 0 diff (100 %id) | ||
BJ992589 | hepatoblastoma | .a | 2020 to 2492 | 1 to 473 | 473/473 (100 %) | 0 diff (100 %id) | |||
T88893 | liver and spleen | .g | 3361 to 3787 | 435 to 4 | 432/438 (98 %) | 0 diff (100 %id) | |||
T84495 | liver and spleen | .a | 2980 to 3278 | 1 to 298 | 298/298 (100 %) | 6 diff (98.0 %id) | |||
R22179 | placenta | .g | 3495 to 3781 | 304 to 11 | 294/442 (66 %) | 0 diff (100 %id) | |||
R54750 | breast | .k | 2045 to 2484 | 1 to 447 | fully sequenced, | 447/447 (100 %) | 14 diff (96.9 %id) | ||
R54938 | breast | .k | 2454 to 2803 | 355 to 1 | tiling clone, fully sequenced, | 355/355 (100 %) | 9 diff (97.5 %id) | ||
H66641 | liver and spleen | .k | 293 to 670 | 1 to 384 | 384/384 (100 %) | 11 diff (97.2 %id) | |||
H66642 | liver and spleen | .k | 1047 to 1492 | 455 to 1 | 455/460 (98 %) | 15 diff (96.8 %id) | |||
H69471 | liver and spleen | .k | 297 to 661 | 18 to 386 | 369/418 (88 %) | 6 diff (98.6 %id) | |||
H69876 | liver and spleen | .k | 1070 to 1467 | 401 to 1 | 401/401 (100 %) | 7 diff (98.3 %id) | |||
N23590 | melanocyte | .a | 883 to 1355 | 11 to 500 | 490/501 (97 %) | 26 diff (94.9 %id) | |||
N21080 | melanocyte | .a | 1742 to 2197 | 457 to 1 | 457/457 (100 %) | 1 diff (99.8 %id) | |||
N27916 | melanocyte | .a | 940 to 1342 | 1 to 404 | 404/406 (99 %) | 3 diff (99.3 %id) | |||
N51997 | multiple sclerosis lesions | .g | 3306 to 3790 | 491 to 1 | 491/506 (97 %) | 20 diff (96.1 %id) | |||
N51347 | multiple sclerosis lesions | .g | 3315 to 3790 | 476 to 1 | 476/480 (99 %) | 3 diff (99.4 %id) | |||
AA112315 | .a | 2820 to 3212 | 402 to 10 | 393/402 (97 %) | 2 diff (99.6 %id) | ||||
AA113107 | .a | 2439 to 2804 | 1 to 370 | 370/402 (92 %) | 5 diff (98.8 %id) | ||||
AA253082 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3437 to 3810 | 374 to 1 | 374/374 (100 %) | 5 diff (98.7 %id) | |||
AA253252 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1269 to 1602 | 1 to 335 | 335/335 (100 %) | 2 diff (99.5 %id) | |||
AA280271 | germinal center B cell | .k | 1013 to 1331 | 319 to 1 | fully sequenced, | 319/319 (100 %) | 0 diff (100 %id) | ||
AA280567 | germinal center B cell | .k | 696 to 1036 | 1 to 340 | fully sequenced, | 340/340 (100 %) | 1 diff (99.8 %id) | ||
AA491986 | Ewing's sarcoma | .g | 3473 to 3793 | 348 to 28 | 321/348 (92 %) | 0 diff (100 %id) | |||
AA629972 | lung, lung carcinoma | .a | 3114 to 3282 | 1 to 169 | Submitted on the opposite strand | 169/169 (100 %) | 1 diff (99.5 %id) | ||
AA587951 | colon, colon tumor RER+ | .a | 3320 to 3822 | 504 to 1 | 504/504 (100 %) | 7 diff (98.7 %id) | |||
AA766332 | germinal center B cell | .g | 3514 to 3793 | 294 to 15 | 280/294 (95 %) | 0 diff (100 %id) | |||
AA748572 | germinal center B cell | .g | 3433 to 3790 | 363 to 6 | 358/363 (98 %) | 0 diff (100 %id) | |||
AA846820 | parathyroid gland, parathyroid tumor | .a | 3293 to 3823 | 541 to 12 | AAA | 530/530 (100 %) | 2 diff (99.7 %id) | ||
AA917929 | Kidney | .g | 3374 to 3789 | 425 to 11 | AAA | 415/415 (100 %) | 1 diff (99.8 %id) | ||
AA913109 | Kidney | .g | 3403 to 3789 | 386 to 1 | 386/386 (100 %) | 1 diff (99.8 %id) | |||
AA988239 | carcinoid, lung | .g | 3425 to 3790 | 367 to 2 | 366/367 (99 %) | 0 diff (100 %id) | |||
AI080755 | .g | 3369 to 3789 | 435 to 15 | AAA | 421/421 (100 %) | 0 diff (100 %id) | |||
AI218089 | pooled | .a | 1598 to 1892 | 298 to 4 | 295/298 (98 %) | 0 diff (100 %id) | |||
AI284657 | ovary, tumor, 5 pooled (see description) | .g | 3500 to 3790 | 293 to 3 | 291/293 (99 %) | 0 diff (100 %id) | |||
AI289529 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .g | 3395 to 3789 | 395 to 1 | 395/395 (100 %) | 0 diff (100 %id) | |||
AI357401 | brain, glioblastoma (pooled) | .g | 3038 to 3793 | 760 to 8 | tiling clone, | 753/811 (92 %) | 23 diff (97.2 %id) | ||
AI362238 | brain, glioblastoma (pooled) | .g | 3320 to 3791 | 472 to 1 | 472/472 (100 %) | 0 diff (100 %id) | |||
AI609772 | brain, glioblastoma (pooled) | .f | 2004 to 2471 | 468 to 1 | 468/468 (100 %) | 0 diff (100 %id) | |||
AI393049 | B-cell, chronic lymphotic leukemia | .g | 3239 to 3789 | 551 to 1 | 551/551 (100 %) | 14 diff (97.5 %id) | |||
AI474416 | Prostate | .g | 3423 to 3789 | 368 to 1 | 368/369 (99 %) | 1 diff (99.8 %id) | |||
AI880675 | colon | .a | 3294 to 3358 | 67 to 3 | 65/67 (97 %) | 0 diff (100 %id) | |||
AI571709 | adenocarcinoma, Pancreas | .g | 3397 to 3789 | 415 to 23 | AAA | 393/393 (100 %) | 7 diff (98.3 %id) | ||
AI625826 | Kidney | .k | 2291 to 2796 | 514 to 9 | 506/514 (98 %) | 0 diff (100 %id) | |||
AI671887 | pooled germ cell tumors | .g | 3038 to 3790 | 752 to 3 | 750/760 (98 %) | 12 diff (98.5 %id) | |||
AI707636 | aorta | .g | 3426 to 3655 | 230 to 1 | 230/230 (100 %) | 0 diff (100 %id) | |||
AI807116 | pooled | .g | 3202 to 3790 | 590 to 1 | 590/598 (98 %) | 22 diff (96.4 %id) | |||
AI741935 | pooled | .g | 3129 to 3789 | 679 to 19 | AAA | 661/662 (99 %) | 18 diff (97.3 %id) | ||
AW009159 | colon | .g | 3198 to 3790 | 596 to 3 | 594/597 (99 %) | 15 diff (97.5 %id) | |||
AW004836 | colon | .g | 3239 to 3790 | 552 to 1 | 552/552 (100 %) | 3 diff (99.5 %id) | |||
AW073165 | brain, glioblastoma (pooled) | .g | 3042 to 3791 | 748 to 1 | 748/780 (95 %) | 11 diff (98.6 %id) | |||
AW117548 | pooled | .g | 3365 to 3793 | 430 to 2 | 429/430 (99 %) | 0 diff (100 %id) | |||
AW118136 | pooled | .g | 3420 to 3790 | 373 to 3 | 371/373 (99 %) | 0 diff (100 %id) | |||
AW183769 | pooled | .a | 3117 to 3534 | 419 to 2 | 418/419 (99 %) | 0 diff (100 %id) | |||
AW303585 | pooled | .g | 3313 to 3790 | 480 to 3 | 478/480 (99 %) | 0 diff (100 %id) | |||
AW341490 | pooled | .k | 2287 to 2804 | 520 to 3 | 518/520 (99 %) | 0 diff (100 %id) | |||
AW613624 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 3419 to 3823 | 405 to 1 | 405/405 (100 %) | 0 diff (100 %id) | |||
AW663176 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 2379 to 2804 | 1 to 426 | 426/426 (100 %) | 0 diff (100 %id) | |||
BE348881 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .g | 3420 to 3793 | 378 to 5 | 374/378 (98 %) | 0 diff (100 %id) | |||
BE677288 | dorsal root ganglia | .g | 3346 to 3790 | 445 to 1 | 445/445 (100 %) | 0 diff (100 %id) | |||
CB055194 | brain, glioblastoma (pooled) | .g | 3112 to 3791 | 705 to 26 | tiling clone, AAA | 680/680 (100 %) | 0 diff (100 %id) | ||
CB055195 | brain, glioblastoma (pooled) | .g | 1996 to 2582 | 10 to 599 | 590/599 (98 %) | 9 diff (98.5 %id) | |||
BF939756 | brain, glioblastoma (pooled) | .g | 3250 to 3791 | 542 to 1 | 542/542 (100 %) | 1 diff (99.9 %id) | |||
BE541477 | cervix | .a | 2266 to 2951 | 1 to 685 | 685/803 (85 %) | 29 diff (96.4 %id) | |||
BC008328 | Brain, neuroblastoma | .a | 2189 to 3682 | 1 to 1494 | available from MGC, AAA | 1494/1494 (100 %) | 0 diff (100 %id) | ||
BE260052 | brain, neuroblastoma | .a | 2209 to 2967 | 1 to 759 | available from MGC, | 759/759 (100 %) | 16 diff (97.9 %id) | ||
BG256453 | embryonal carcinoma, cell line, testis | .a | 1198 to 1951 | 1 to 779 | 741/1004 (73 %) | 46 diff (95.5 %id) | |||
BG259569 | embryonal carcinoma, cell line, testis | .a | 884 to 1542 | 1 to 669 | 669/677 (98 %) | 27 diff (96.1 %id) | |||
BM470958 | leiomyosarcoma, uterus | .a | 2004 to 2960 | 1 to 973 | 973/1059 (91 %) | 29 diff (97.3 %id) | |||
BM551934 | melanotic melanoma, skin | .a | 2925 to 3541 | 13 to 630 | 618/1084 (57 %) | 59 diff (94.6 %id) | |||
BU169545 | epithelioid carcinoma, Pancreas | .a | 754 to 1677 | 1 to 932 | tiling clone, | 932/937 (99 %) | 43 diff (95.5 %id) | ||
BQ222021 | melanotic melanoma, skin | .a | 169 to 806 | 1 to 640 | 640/909 (70 %) | 4 diff (99.6 %id) | |||
BQ227486 | large cell carcinoma, lung | .a | 798 to 1684 | 1 to 893 | 893/894 (99 %) | 13 diff (98.6 %id) | |||
BQ228605 | melanotic melanoma, skin | .a | 127 to 978 | 1 to 860 | 860/860 (100 %) | 18 diff (98.0 %id) | |||
BQ424404 | eye, retinoblastoma | .a | 1280 to 2167 | 1 to 890 | 888/890 (99 %) | 7 diff (99.3 %id) | |||
BQ425627 | eye, retinoblastoma | .a | 909 to 1751 | 8 to 857 | 850/871 (97 %) | 17 diff (98.1 %id) | |||
BU933032 | mixed (pool of 40 RNAs) | .a | 2748 to 3538 | 1 to 796 | 796/799 (99 %) | 11 diff (98.7 %id) | |||
CX761282 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 646 to 1382 | 1 to 737 | Submitted on the opposite strand | 737/743 (99 %) | 9 diff (98.8 %id) | ||
CX760700 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 2277 to 2940 | 1 to 658 | Submitted on the opposite strand | 658/740 (88 %) | 18 diff (97.6 %id) | ||
CB999625 | Pooled-Skin | .k | 1616 to 2172 | 1 to 562 | 562/757 (74 %) | 32 diff (95.8 %id) | |||
CD556370 | brain, Pituitary | .a | 2219 to 2806 | 7 to 596 | 590/961 (61 %) | 9 diff (99.1 %id) | |||
CD656959 | Embryonic Stem cells | .a | 1397 to 2185 | 9 to 791 | 783/817 (95 %) | 15 diff (98.2 %id) | |||
NM_007349.3 | .a | 113 to 3823 | 1 to 3711 | RefSeq, AAA | 3711/3711 (100 %) | 0 diff (100 %id) | |||
DA716004 | .a | 1630 to 2169 | 2 to 542 | capped | 541/541 (100 %) | 1 diff (99.9 %id) | |||
AU123803 | .a | 826 to 1445 | 2 to 624 | capped | 623/624 (99 %) | 6 diff (99.1 %id) | |||
DA815609 | .a | 1788 to 2357 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | |||
DA872202 | Prostate | .f | 1 to 518 | 2 to 520 | capped | 519/519 (100 %) | 2 diff (99.7 %id) | ||
DB329979 | Prostate | .f | 1915 to 2476 | 562 to 1 | 562/562 (100 %) | 0 diff (100 %id) | |||
CR993144 | T-Lymphocytes | .a | 1 to 402 | 1 to 402 | tiling clone, | 402/402 (100 %) | 3 diff (99.3 %id) | ||
BM844641 | lymph node, stomach | .a | 2624 to 3117 | 1 to 494 | 494/494 (100 %) | 0 diff (100 %id) | |||
BM843454 | lymph node, stomach | .a | 2624 to 3330 | 1 to 707 | 707/707 (100 %) | 0 diff (100 %id) | |||
BM857027 | stomach | .a | 2657 to 2920 | 1 to 264 | 264/266 (99 %) | 1 diff (99.7 %id) | |||
DB002370 | breast, tumor tissue | .a | 1586 to 2116 | 2 to 532 | capped | 531/531 (100 %) | 0 diff (100 %id) | ||
DR002833 | fetal brain | .c | 1 to 423 | 1 to 423 | tiling clone, | 423/426 (99 %) | 6 diff (98.6 %id) | ||
DB064604 | testis | .c | 343 to 930 | 2 to 589 | capped | 588/588 (100 %) | 0 diff (100 %id) | ||
DB072841 | testis | .e | 29 to 576 | 2 to 549 | tiling clone, capped | 548/548 (100 %) | 0 diff (100 %id) | ||
DB340338 | testis | .e | 2545 to 3092 | 548 to 1 | tiling clone, | 548/548 (100 %) | 0 diff (100 %id) | ||
DB074747 | testis | .a | 484 to 1022 | 2 to 541 | capped | 540/540 (100 %) | 1 diff (99.9 %id) | ||
DB099422 | testis | .a | 560 to 1111 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB103234 | thymus | .a | 1420 to 1976 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DB342625 | thymus | .a | 3234 to 3823 | 590 to 1 | 590/590 (100 %) | 0 diff (100 %id) | |||
DB134994 | thymus | .j | 1 to 525 | 2 to 526 | exact | tiling clone, capped | 525/525 (100 %) | 0 diff (100 %id) | |
DB138977 | thymus | .a | 714 to 1256 | 2 to 544 | capped | 543/543 (100 %) | 0 diff (100 %id) | ||
DB146047 | thymus | .a | 1268 to 1818 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
DB154473 | thymus | .c | 48 to 626 | 2 to 580 | capped | 579/579 (100 %) | 1 diff (99.9 %id) | ||
DB159947 | thymus | .m | 1 to 600 | 2 to 602 | exact | tiling clone, capped | 601/601 (100 %) | 1 diff (99.9 %id) | |
TI_154027596 | .g | 3178 to 3789 | 749 to 141 | AAA | 609/788 (77 %) | 16 diff (98.0 %id) | |||
U23862 | skeletal muscle | .a | 1525 to 2148 | 630 to 7 | Submitted on the opposite strand | 624/633 (98 %) | 4 diff (99.4 %id) | ||
CA442014 | lung, Metastatic Chondrosarcoma | .g | 3315 to 3789 | 493 to 19 | AAA | 475/481 (98 %) | 5 diff (99.0 %id) | ||
BQ574335 | Chondrosarcoma Grade II, Left Pelvis | .g | 3142 to 3789 | 666 to 19 | AAA | 648/648 (100 %) | 0 diff (100 %id) | ||
DB282936 | uterus | .a | 719 to 1210 | 2 to 493 | capped | 492/492 (100 %) | 0 diff (100 %id) | ||
DB283274 | uterus | .b | 855 to 1404 | 2 to 552 | tiling clone, capped | 551/551 (100 %) | 2 diff (99.7 %id) | ||
Z78327 | brain | .k | 1616 to 2172 | 1 to 562 | Suspected internal deletion, this clone was ignored | 562/757 (74 %) | 32 diff (95.8 %id) | ||
AA448349 | .a | 2219 to 2806 | 7 to 596 | This clone was ignored | 590/961 (61 %) | 9 diff (99.1 %id) | |||
AA496913 | .a | 2219 to 2806 | 7 to 596 | This clone was ignored | 590/961 (61 %) | 9 diff (99.1 %id) | |||
AA497075 | .a | 1397 to 2185 | 9 to 791 | This clone was ignored | 783/817 (95 %) | 15 diff (98.2 %id) | |||
BU175987 | eye, retinoblastoma | .a | 113 to 3823 | 1 to 3711 | RefSeq, | Suspected internal deletion, suspected internal deletion, this clone was ignored | 3711/3711 (100 %) | 0 diff (100 %id) | |
BM820628 | stomach | .a | 1630 to 2169 | 2 to 542 | Suspected internal deletion, this clone was ignored | 541/541 (100 %) | 1 diff (99.9 %id) | ||
DB085562 | testis | .a | 826 to 1445 | 2 to 624 | capped | This clone was ignored | 623/624 (99 %) | 6 diff (99.1 %id) | |
DB341101 | testis | .a | 1788 to 2357 | 2 to 571 | This clone was ignored | 570/570 (100 %) | 0 diff (100 %id) | ||
U80735 | brain | .f | 1 to 518 | 2 to 520 | AAA | Suspected internal deletion, suspected internal deletion, this clone was ignored | 519/519 (100 %) | 2 diff (99.7 %id) | |
DB329979 | Prostate | .f | 1915 to 2476 | 562 to 1 | 562/562 (100 %) | 0 diff (100 %id) | |||
CR993144 | T-Lymphocytes | .a | 1 to 402 | 1 to 402 | tiling clone, | 402/402 (100 %) | 3 diff (99.3 %id) | ||
BM844641 | lymph node, stomach | .a | 2624 to 3117 | 1 to 494 | 494/494 (100 %) | 0 diff (100 %id) | |||
BM844641 | lymph node, stomach | .a | 2624 to 3117 | 1 to 494 | 494/494 (100 %) | 0 diff (100 %id) | |||
BM843454 | lymph node, stomach | .a | 2624 to 3330 | 1 to 707 | 707/707 (100 %) | 0 diff (100 %id) | |||
BM843454 | lymph node, stomach | .a | 2624 to 3330 | 1 to 707 | 707/707 (100 %) | 0 diff (100 %id) | |||
BM857027 | stomach | .a | 2657 to 2920 | 1 to 264 | 264/266 (99 %) | 1 diff (99.7 %id) | |||
DB002370 | breast, tumor tissue | .a | 1586 to 2116 | 2 to 532 | capped | 531/531 (100 %) | 0 diff (100 %id) | ||
DR002833 | fetal brain | .c | 1 to 423 | 1 to 423 | tiling clone, | 423/426 (99 %) | 6 diff (98.6 %id) | ||
DB064604 | testis | .c | 343 to 930 | 2 to 589 | capped | 588/588 (100 %) | 0 diff (100 %id) | ||
DB072841 | testis | .e | 29 to 576 | 2 to 549 | tiling clone, capped | 548/548 (100 %) | 0 diff (100 %id) | ||
DB340338 | testis | .e | 2545 to 3092 | 548 to 1 | tiling clone, | 548/548 (100 %) | 0 diff (100 %id) | ||
DB074747 | testis | .a | 484 to 1022 | 2 to 541 | capped | 540/540 (100 %) | 1 diff (99.9 %id) | ||
DB099422 | testis | .a | 560 to 1111 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB103234 | thymus | .a | 1420 to 1976 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DB342625 | thymus | .a | 3234 to 3823 | 590 to 1 | 590/590 (100 %) | 0 diff (100 %id) | |||
DB134994 | thymus | .j | 1 to 525 | 2 to 526 | exact | tiling clone, capped | 525/525 (100 %) | 0 diff (100 %id) | |
DB138977 | thymus | .a | 714 to 1256 | 2 to 544 | capped | 543/543 (100 %) | 0 diff (100 %id) | ||
DB146047 | thymus | .a | 1268 to 1818 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
DB154473 | thymus | .c | 48 to 626 | 2 to 580 | capped | 579/579 (100 %) | 1 diff (99.9 %id) | ||
DB159947 | thymus | .m | 1 to 600 | 2 to 602 | exact | tiling clone, capped | 601/601 (100 %) | 1 diff (99.9 %id) | |
TI_154027596 | .g | 3178 to 3789 | 749 to 141 | AAA | 609/788 (77 %) | 16 diff (98.0 %id) | |||
U23862 | skeletal muscle | .a | 1525 to 2148 | 630 to 7 | Submitted on the opposite strand | 624/633 (98 %) | 4 diff (99.4 %id) | ||
CA442014 | lung, Metastatic Chondrosarcoma | .g | 3315 to 3789 | 493 to 19 | AAA | 475/481 (98 %) | 5 diff (99.0 %id) | ||
CA442014 | lung, Metastatic Chondrosarcoma | .g | 3315 to 3789 | 493 to 19 | AAA | 475/481 (98 %) | 5 diff (99.0 %id) | ||
BQ574335 | Chondrosarcoma Grade II, Left Pelvis | .g | 3142 to 3789 | 666 to 19 | AAA | 648/648 (100 %) | 0 diff (100 %id) | ||
BQ574335 | Chondrosarcoma Grade II, Left Pelvis | .g | 3142 to 3789 | 666 to 19 | AAA | 648/648 (100 %) | 0 diff (100 %id) | ||
DB282936 | uterus | .a | 719 to 1210 | 2 to 493 | capped | 492/492 (100 %) | 0 diff (100 %id) | ||
DB283274 | uterus | .b | 855 to 1404 | 2 to 552 | tiling clone, capped | 551/551 (100 %) | 2 diff (99.7 %id) |